Resources Contact Us Home
Recombinant vaccine for diseases caused by encapsulated organisms

Image Number 5 for United States Patent #6326001.

Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organisms. As an example, a live, attenuated strain of Actinobacillus pleuropneumoniae genetically modified with a large deletion in a chromosomal regions of the DNA which encodes for capsule synthesis is a safe and effective vaccine against swine pleuropneumonia.

  Recently Added Patents
System and method of improving audio signals for the hearing impaired
Establishing a social network
Bioactive agent-loaded heart-targeting nanoparticles
Campanula plant named `PKMM03`
Computerized apparatus for identifying industries for potential transfer of a job function
Hard disk drives having different rotational speeds
Method and apparatus for power management control of an embedded memory having sleep and shutdown features
  Randomly Featured Patents
Noise suppression in memory device sensing
Purification of aluminum chloride
Ammonia-based plasma treatment for metal fill in narrow features
Continuous vapor phase process for direct conversion of methanol to higher alcohols
Fluid pressure circuit
Code-division multiple-access system with improved utilization of upstream and downstream channels
Spacer for interposition between a temperature-controlled plate and a pressure plate of a press
Grounding detection circuit
Carrying cart for petroleum measuring and proving cans